
    
      The proposed study, is a randomized placebo controlled cross-over study for 6 months, with an
      open label extension for another 6 months designed to test the benefits and safety of MCT oil
      in patients with established AD. It will be the first study on MCT oil ever done with this
      design, and for this duration in AD.
    
  